JZP327A

A potent human FAAH inhibitor.

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Migraine Disorders (Migraine) 06/14/2023 - "Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine." 06/14/2023 - "Here, we profile the pharmacological activity of the FAAH inhibitor JZP327A, a chiral 1,3,4-oxadiazol-2(3H)-one compound, in the mediation of spontaneous and nocifensive behaviour in the animal models of migraine based on nitroglycerin (NTG) administration. "
2.	Hyperalgesia 06/14/2023 - "The findings show that JZP327A did not affect NTG-induced changes in the spontaneous behaviour of rats, while it inhibited NTG-induced hyperalgesia at the orofacial formalin test. "